Grant: Engage Grants Program
University of British Columbia
$25,000.00
Synthesis of investigational agents AUR1401 and AUR1402
EF 2014-15
Résumé
The complement system is a major component of our innate immune system. Unwanted activation of thecomplement system is known or thought to occur in a wide range of diseases, including paroxysmal nocturnalhemoglobinemia, age related macular degeneration, multiple sclerosis, Alzheimer disease, Parkinson diseaseand Lou Gehrig's disease. The evolutionary role of the complement system is to recognize and attack invadersand to get rid of damaged tissue. There are two parts to activation. The first part prepares dead tissue to beeliminated from the body by phagocytosis. The second part, known as the membrane attack complex (MAC),forms transmembrane channels in cells, which leads to cell death by disruption of the phospholipid bilayer.Although the role of MAC is to destroy invading pathogens, it can act against the host. This ""self-attack""occurs in many human diseases, as noted above. Aurin tricarboxylic acid (ATA) and analogues (e.g., structures2 and 3, as indicated in the proposal) are the only orally-effective agents that block pathological activation ofthe complement system.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
462718-2014
Name nom
Love, Jennifer
Department département
Chemistry
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
3703
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic syntheses
Research subject fr
Synthèses organiques
Partie
1
Nb partie
1
Application title
Synthesis of investigational agents AUR1401 and AUR1402
Keyword
NSERC
Application summary
The complement system is a major component of our innate immune system. Unwanted activation of thecomplement system is known or thought to occur in a wide range of diseases, including paroxysmal nocturnalhemoglobinemia, age related macular degeneration, multiple sclerosis, Alzheimer disease, Parkinson diseaseand Lou Gehrig's disease. The evolutionary role of the complement system is to recognize and attack invadersand to get rid of damaged tissue. There are two parts to activation. The first part prepares dead tissue to beeliminated from the body by phagocytosis. The second part, known as the membrane attack complex (MAC),forms transmembrane channels in cells, which leads to cell death by disruption of the phospholipid bilayer.Although the role of MAC is to destroy invading pathogens, it can act against the host. This ""self-attack""occurs in many human diseases, as noted above. Aurin tricarboxylic acid (ATA) and analogues (e.g., structures2 and 3, as indicated in the proposal) are the only orally-effective agents that block pathological activation ofthe complement system.